Startups

Spirea develops targeted antibody-drug conjugates designed to improve cancer treatment efficacy and safety.

Stingray Bio develops small molecule inhibitors to target the LMTK3 kinase signalling pathway in cancer treatment.

Syndex Bio advances next-generation molecular diagnostics with its proprietary methyl-copying PCR platform.

Synthace provides a cloud platform that enables life scientists to automate experiments and share insights.

Developer of next-generation T cell receptor therapeutics for oncology and immunology.

Tenpoint Therapeutics develops engineered cell-based therapies to restore vision.

Tharos creates enzyme rich malt extract supplements to improve animal gut health and performance.

The company manufactures clinical-grade electrospun biomaterials to support tissue repair and medical device development.

Turbine builds cell simulation software to predict cancer treatment outcomes.

Upfront Diagnostics develops rapid point-of-care blood tests for the rapid detection of strokes.